Aurobindo Pharma is a fast track integrated pharmaceutical company headquartered in Hyderabad, India, producing and marketing some of the most quality conscious Active Pharmaceutical Ingredients (bulk actives), intermediates and speciality generic formulations.
It ranks among the top 5 pharma companies in India and is a multi product, multi technology, transnational company. Today the Company�s products are serving consumers in India and over 100 other countries.
Aurobindo Pharma is an R&D driven chemistry business house, with a very broad product portfolio. The Company has a presence in fast growing life style disease drugs, anti infective drugs and key speciality therapeutics.
The Company is a known leader in the semi synthetic penicillins and cephalosporins. Indeed, Aurobindo seeks to attain significant market presence in every area of its business. After creating a name for itself in producing APIs and intermediates, Aurobindo Pharma sees major growth in its speciality generic formulations business.
Aurobindo Pharma values its contribution to its customers and the medical profession. The Company has accordingly planned its strategic growth, proactively responded to the changing requirements of the medical profession, and enabled its core customers to meet their market needs
The customers of the Company benefit from the most modern and state-of-the-art manufacturing facilities and a quality conscious approach to business. Aurobindo Pharma believes in delivering value in every transaction.
The Company sees its potential both in regulated and other global markets. In regulated markets, Aurobindo Pharma visualises profits aided by the thrust in building intellectual property. In the large growth segments of other global markets, the Company will succeed by virtue of its cost efficient production.
Volumes have been ensured by expanding capacities in the remunerative/demand pull segments. In turn, this has provided economies of scale. Aurobindo Pharma takes care to remain a quality conscious cost efficient producer.